A post-hoc analysis of ACTT-2 (Adaptive COVID-19 Treatment Trial-2) found that the use of a risk profile may more precisely characterize high-risk patients who may benefit from the use of baricitinib. The analysis is published ...
Feb 26, 2024
0
0
Patients with weakened immune systems could be inadvertently helping COVID-19 develop resistance to the antiviral drug remdesivir, a new study reports.
Jan 23, 2024
0
1
Remdesivir was one of the first medications approved for treatment of COVID-19. Clinical studies evaluated its effectiveness, but did not generate conclusive results. A new analysis of the study data shows that a specific ...
Feb 22, 2023
1
24
The COVID-19 pandemic has led to an explosion of clinical research resulting in the development of a variety of vaccines and treatments, although the efficacy of some remains controversial. Now, researchers from Japan report ...
Nov 22, 2022
0
27
The antibody drugs sotrovimab and casirivimab-imdevimab are not recommended for patients with COVID-19, says a WHO Guideline Development Group of international experts in The BMJ today.
Sep 15, 2022
0
134
Do patients with prolonged infections contribute to the emergence of new SARS-CoV-2 variants? A research team from the Leibniz Institute of Virology (LIV) and the University Medical Center Hamburg-Eppendorf (UKE) has investigated ...
Aug 17, 2022
0
75
For patients with severe COVID-19 requiring high flow nasal cannula (HFNC), triple therapy of dexamethasone, remdesivir, and baricitinib is associated with significant survival benefit compared with dual therapy, according ...
Aug 12, 2022
0
14
A monoclonal antibody treatment taken by patients hospitalized with COVID-19 did not improve recovery time but did reduce deaths, according to a study published July 8 in The Lancet Respiratory Medicine.
Jul 11, 2022
0
139
For hospitalized patients with COVID-19 requiring supplemental oxygen, baricitinib plus remdesivir and dexamethasone plus remdesivir result in similar mechanical ventilation-free survival by day 29, but adverse events occur ...
Jun 21, 2022
0
16
Determining how SARS-CoV-2, the virus causing COVID-19, moves from an early stage of infection, when patients are largely asymptomatic, into a later stage in which people may experience life-threatening inflammation in the ...
Jun 14, 2022
0
186
